Q4 2025 earnings call recap: record sales, Germany turnaround, DrugSorb-ATR FDA progress, and breakeven target.
Q4 2025 Earnings Call March 25, 2026 4:30 PM EDTCompany ParticipantsPeter Mariani - Chief Financial OfficerPhillip Chan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results